BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tavares GS, Mendonça DV, Miyazaki CK, Lage DP, Soyer TG, Carvalho LM, Ottoni FM, Dias DS, Ribeiro PA, Antinarelli LM, Ludolf F, Duarte MC, Coimbra ES, Chávez-fumagalli MA, Roatt BM, Menezes-souza D, Barichello JM, Alves RJ, Coelho EA. A Pluronic® F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection. Parasitology International 2019;68:63-72. [DOI: 10.1016/j.parint.2018.10.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Tuon FF, Dantas LR, de Souza RM, Ribeiro VST, Amato VS. Liposomal drug delivery systems for the treatment of leishmaniasis. Parasitol Res. [DOI: 10.1007/s00436-022-07659-5] [Reference Citation Analysis]
2 Singh V, Eljaaly K, Md S, Alhakamy NA, Kesharwani P. Triblock copolymeric drug delivery as an emerging nanocarrier for treatment of infectious diseases. Journal of Drug Delivery Science and Technology 2022;75:103691. [DOI: 10.1016/j.jddst.2022.103691] [Reference Citation Analysis]
3 Figueiras A, Domingues C, Jarak I, Santos AI, Parra A, Pais A, Alvarez-lorenzo C, Concheiro A, Kabanov A, Cabral H, Veiga F. New Advances in Biomedical Application of Polymeric Micelles. Pharmaceutics 2022;14:1700. [DOI: 10.3390/pharmaceutics14081700] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Machado AS, Lage DP, Vale DL, Freitas CS, Linhares FP, Cardoso JMO, Pereira IAG, Ramos FF, Tavares GSV, Ludolf F, Oliveira-da-Silva JA, Bandeira RS, Simões AC, Duarte MC, Oliveira JS, Christodoulides M, Chávez-Fumagalli MA, Roatt BM, Martins VT, Coelho EAF. A recombinant Leishmania amastigote-specific protein, rLiHyG, with adjuvants, protects against infection with Leishmania infantum. Acta Trop 2022;230:106412. [PMID: 35305943 DOI: 10.1016/j.actatropica.2022.106412] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Mendonça DVC, Tavares GSV, Pereira IAG, Oliveira-da-Silva JA, Ramos FF, Lage DP, Machado AS, Carvalho LM, Reis TAR, Carvalho AMRS, Ottoni FM, Ludolf F, Freitas CS, Martins VT, Chávez-Fumagalli MA, Duarte MC, Humbert MV, Roatt BM, Menezes-Souza D, Alves RJ, Coelho EAF. Flau-A, a naphthoquinone derivative, is a promising therapeutic candidate against visceral leishmaniasis: A preliminary study. Exp Parasitol 2021;:108205. [PMID: 34968460 DOI: 10.1016/j.exppara.2021.108205] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Toscanini MA, Limeres MJ, Garrido AV, Cagel M, Bernabeu E, Moretton MA, Chiappetta DA, Cuestas ML. Polymeric micelles and nanomedicines: Shaping the future of next generation therapeutic strategies for infectious diseases. Journal of Drug Delivery Science and Technology 2021;66:102927. [DOI: 10.1016/j.jddst.2021.102927] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Costa RR, Oliveira-da-Silva JA, Reis TAR, Tavares GSV, Mendonça DVC, Freitas CS, Lage DP, Martins VT, Antinarelli LMR, Machado AS, Bandeira RS, Ludolf F, Santos TTO, Brito RCF, Humbert MV, Menezes-Souza D, Duarte MC, Chávez-Fumagalli MA, Roatt BM, Coimbra ES, Coelho EAF. Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis. Med Microbiol Immunol 2021;210:133-47. [PMID: 33870453 DOI: 10.1007/s00430-021-00707-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Hwang D, Ramsey JD, Kabanov AV. Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. Adv Drug Deliv Rev 2020;156:80-118. [PMID: 32980449 DOI: 10.1016/j.addr.2020.09.009] [Cited by in Crossref: 68] [Cited by in F6Publishing: 81] [Article Influence: 34.0] [Reference Citation Analysis]
9 Pereira IAG, Mendonça DVC, Tavares GSV, Lage DP, Ramos FF, Oliveira-da-Silva JA, Antinarelli LMR, Machado AS, Carvalho LM, Carvalho AMRS, Salustiano IV, Reis TAR, Bandeira RS, Silva AM, Martins VT, Chávez-Fumagalli MA, Humbert MV, Roatt BM, Duarte MC, Menezes-Souza D, Coimbra ES, Leite JPV, Coelho EAF, Gonçalves DU. Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis. Parasite Immunol 2020;42:e12784. [PMID: 32772379 DOI: 10.1111/pim.12784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
10 Zarrintaj P, Ramsey JD, Samadi A, Atoufi Z, Yazdi MK, Ganjali MR, Amirabad LM, Zangene E, Farokhi M, Formela K, Saeb MR, Mozafari M, Thomas S. Poloxamer: A versatile tri-block copolymer for biomedical applications. Acta Biomater 2020;110:37-67. [PMID: 32417265 DOI: 10.1016/j.actbio.2020.04.028] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 37.5] [Reference Citation Analysis]
11 Tavares GSV, Mendonça DVC, Pereira IAG, Oliveira-da-Silva JA, Ramos FF, Lage DP, Machado AS, Carvalho LM, Reis TAR, Perin L, Carvalho AMRS, Ottoni FM, Ludolf F, Freitas CS, Bandeira RS, Silva AM, Chávez-Fumagalli MA, Duarte MC, Menezes-Souza D, Alves RJ, Roatt BM, Coelho EAF. A clioquinol-containing Pluronic® F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine model. Parasite 2020;27:29. [PMID: 32351209 DOI: 10.1051/parasite/2020027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
12 Carvalho SG, Araujo VHS, Dos Santos AM, Duarte JL, Silvestre ALP, Fonseca-Santos B, Villanova JCO, Gremião MPD, Chorilli M. Advances and challenges in nanocarriers and nanomedicines for veterinary application. Int J Pharm 2020;580:119214. [PMID: 32165220 DOI: 10.1016/j.ijpharm.2020.119214] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
13 Martínez-Rodrigo A, S Dias D, Ribeiro PAF, Roatt BM, Mas A, Carrión J, Coelho EAF, Domínguez-Bernal G. Immunization with the HisAK70 DNA Vaccine Induces Resistance against Leishmania Amazonensis Infection in BALB/c Mice. Vaccines (Basel) 2019;7:E183. [PMID: 31739549 DOI: 10.3390/vaccines7040183] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
14 Vigato AA, Querobino SM, de Faria NC, Candido ACBB, Magalhães LG, Cereda CMS, Tófoli GR, Campos EVR, Machado IP, Fraceto LF, de Sairre MI, de Araujo DR. Physico-Chemical Characterization and Biopharmaceutical Evaluation of Lipid-Poloxamer-Based Organogels for Curcumin Skin Delivery. Front Pharmacol 2019;10:1006. [DOI: 10.3389/fphar.2019.01006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
15 Sousa JKT, Antinarelli LMR, Mendonça DVC, Lage DP, Tavares GSV, Dias DS, Ribeiro PAF, Ludolf F, Coelho VTS, Oliveira-da-Silva JA, Perin L, Oliveira BA, Alvarenga DF, Chávez-Fumagalli MA, Brandão GC, Nobre V, Pereira GR, Coimbra ES, Coelho EAF. A chloroquinoline derivate presents effective in vitro and in vivo antileishmanial activity against Leishmania species that cause tegumentary and visceral leishmaniasis. Parasitol Int 2019;73:101966. [PMID: 31362122 DOI: 10.1016/j.parint.2019.101966] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]